Navigation Links
Spinal Cord Stimulation Pilot Study for Chronic Angina

St. Jude Medical, Inc. today announced the first patient implant in a pilot study that will preliminarily evaluate if stimulating nerves near the spinal cord will control// chronic chest pain caused by angina.

A 53-year-old Massachusetts woman is the first person to receive this investigational device, called the Genesis? Neurostimulation System. She is one of approximately 1.3 million Americans who suffer from chronic angina, according to the American Heart Association (AHA), with 75,000 new cases of treatment-resistant angina occurring each year.

The Genesis System was developed by St. Jude Medical’s neuromodulation division, Advanced Neuromodulation Systems (ANS).

“There are an increasing number of patients with coronary artery disease who have exhausted available medical and surgical treatment options,” said Roger Laham, M.D., interventional cardiologist with Harvard Medical School and Beth Israel Deaconess Medical Center in Boston, Mass., who is the principal investigator for the trial. “These patients struggle with disabling angina and are commonly referred to as ‘no-option’ patients.”

“The procedure went smoothly,” said Thomas Simopoulos, M.D., interventional pain specialist with the Arnold Pain Management Center at Beth Israel Deaconess Medical Center, who performed the implant. “I am hopeful that spinal cord stimulation will offer a minimally invasive treatment option for patients with chronic, intractable angina.”

Angina is chest pain or discomfort that occurs when the heart muscle does not get as much oxygen as it needs. The pain is often described as a squeezing pain in the chest, shoulders, arms, neck, jaw or back and is sometimes described as feeling like indigestion. Angina is one of the most common symptoms of coronary artery disease which is a leading cause of death in the U.S.

Chronic angina is chest pain that persists. Many with this condition have to live with constant or rec urring pain and loss of function. For a number of these people, medications such as nitroglycerin do not work, and surgical procedures such as angioplasty, stenting or bypass, are considered to be too risky by their doctors.

“The angina clinical trial is an important step forward in our commitment to provide pain solutions for people who don’t have a lot of other options,” said Chris Chavez, president of ANS.

Spinal cord stimulation (SCS) is a therapy that uses mild electrical pulses from an implanted device to stimulate targeted nerves. An SCS device looks and operates much like a cardiac pacemaker, except that instead of sending pulses to the heart, it sends them to leads located near the spinal cord. In this trial, SCS is being tested to see if it interrupts angina pain signals.

To be eligible to participate in the chronic angina pilot study, patients must be 18 years of age or older, have been diagnosed with inoperable coronary artery disease, and be experiencing a minimum of five angina episodes per week. Patients must also be diagnosed with functional class III or class IV angina, categorized according to the Canadian Cardiovascular Society (CCS) scale.

Source-Neswise
SRM
'"/>




Related medicine news :

1. Spinal Cord Patients Walk Again
2. Hope for Babies Born With Spinal Muscular Atrophy
3. New Findings Could Reduce The Extent Of Spinal Cord Injuries
4. Effective Diagnosis Of Spinal Cord Injuries
5. Treatment May Be Possible For Degenerative Brain And Spinal Cord Disease
6. Titanium Rib Found To Be Effective In Treating Spinal Deformities In Children
7. New Therapy Recommendations For Spinal Complications Of Cancer
8. Nerve regeneration for Spinal cord injuries
9. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
10. Hope After Spinal Cord Injuries
11. Stem Cell Technology Gives Hope in Spinal Cord Injuries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... ... The Waismann Method® is providing a faster, safer, and more ... to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... shame, stigma, and harmful labeling believed to prevent many of these victims ...
(Date:2/22/2017)... ... ... South Bend’s Lunkerville, the award-winning TV series that catches real people with real ... non-profit organization dedicated to helping military veterans relax, rehabilitate, and reintegrate through kayak fishing. ... Denmark, New Jersey, to fish with war veteran Justin Vail from the New Jersey ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... adults with chronic conditions reported skipping doses or not filling a prescription because ... or under-insured, rates of cost-related problems getting medications were 30-60%*. At ...
(Date:2/22/2017)... ... 22, 2017 , ... Sideline Products participated in the World Horse Expo held ... Seay and his production crew. Tom Seay’s program “Best of America by Horseback” ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the clip ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National Heart ... advocates, and individuals join together to increase recognition about the risks of heart ... , “Today we mark a nationwide movement to raise awareness about a disease ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... quarter and full year 2016 financial results on Thursday, March ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 p.m. ... obtained as follows: Thursday, March 2 1:30 ...
(Date:2/22/2017)... 2017  Andre, DiMino, CEO of ADM Tronics Unlimited, ... innovative technologies and products, commented on ADMT,s third quarter ... 2017 in the Company,s quarterly report on Form 10Q ... Andre, DiMino stated "During the quarter ended December 31, ... a larger portion of our engineering efforts into the ...
(Date:2/22/2017)... Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer ... the semiconductor capital equipment, flat panel, medical, energy ... for the fourth quarter and fiscal year ended ... year of extraordinary growth for UCT. Total revenue ... with continued focus on operational excellence resulted in ...
Breaking Medicine Technology: